Immunome (IMNM) Income Statement (2019 - 2026)
Income Statement report data from Sep 30, 2019 to Mar 31, 2026 for Immunome (IMNM).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||||||
Total Revenue | - | - | - | 4.01M (+36.86%) | 2.93M (+6.93%) | 2.74M (-5.84%) | 2.91M (+23.31%) | 2.36M (+129.13%) | 1.03M (-73.11%) | 3.83M (+7.28%) | 3.57M (-16.20%) | 4.26M (+80.51%) | 2.36M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | ||||||||||||||||||||||||||
Research And Development | 46M (-8.65%) | 51M (+3.21%) | 49M (+21.61%) | 40M (+9.71%) | 37M (-23.01%) | 48M (+28.74%) | 37M (+27.92%) | 29M (+89.20%) | 15M (+59.44%) | 9.64M (+152.36%) | 3.82M (-33.22%) | 5.72M (+46.29%) | 3.91M (-8.00%) | 4.25M (-18.74%) | 5.23M (-8.57%) | 5.72M (-29.21%) | 8.08M (+84.05%) | 4.39M (-2.66%) | 4.51M (+39.63%) | 3.23M (+63.13%) | 1.98M (+7.61%) | 1.84M (+12.20%) | 1.64M (-13.23%) | 1.89M (-10.85%) | 2.12M (-4.93%) | 2.23M |
Selling General And Administrative | 13M (+7.11%) | 12M (+10.41%) | 11M (+9.06%) | 10M (-6.08%) | 11M (+2.30%) | 10M (+9.65%) | 9.53M (+36.53%) | 6.98M (+16.14%) | 6.01M (-25.25%) | 8.04M (+83.56%) | 4.38M (+1.39%) | 4.32M (+47.95%) | 2.92M (-17.51%) | 3.54M (+6.95%) | 3.31M (+3.12%) | 3.21M (-10.34%) | 3.58M (+3.47%) | 3.46M (+7.79%) | 3.21M (+27.89%) | 2.51M (+30.73%) | 1.92M (-14.29%) | 2.24M (+91.45%) | 1.17M (+42.68%) | 820K (+51.85%) | 540K (+10.20%) | 490K |
Operating Expenses | 59M (-18.57%) | 73M (+21.15%) | 60M (+19.11%) | 50M (+6.16%) | 48M (-44.51%) | 86M (+60.42%) | 53M (+26.10%) | 42M (-68.22%) | 133M (+35.39%) | 98M (+1100.98%) | 8.20M (-18.33%) | 10M (+46.78%) | 6.84M (-12.20%) | 7.79M (-8.68%) | 8.53M (-4.48%) | 8.93M (-23.35%) | 12M (+48.60%) | 7.84M (+1.55%) | 7.72M (+34.49%) | 5.74M (+47.18%) | 3.90M (-4.18%) | 4.07M (+44.33%) | 2.82M (+3.68%) | 2.72M (+2.26%) | 2.66M (-2.21%) | 2.72M |
Depreciation And Amortization | 600K (-67.74%) | 1.86M | - | - | 610K (-56.74%) | 1.41M | - | - | 160K (-55.56%) | 360K | - | - | 90K (-70.97%) | 310K | - | - | 110K (-81.03%) | 580K | - | - | 180K (-69.49%) | 590K | - | - | 160K | - |
Operating Income | ||||||||||||||||||||||||||
Operating Income | -59.33M (-18.57%) | -72.86M (+21.15%) | -60.14M (+29.39%) | -46.48M (+4.12%) | -44.64M (-46.20%) | -82.97M (+64.23%) | -50.52M (+26.27%) | -40.01M (-69.76%) | -132.30M (+39.78%) | -94.65M (+1944.28%) | -4.63M (-19.76%) | -5.77M (+29.08%) | -4.47M (-42.62%) | -7.79M (-8.68%) | -8.53M (-4.48%) | -8.93M (-23.35%) | -11.65M (+48.60%) | -7.84M (+1.55%) | -7.72M (+34.49%) | -5.74M (+47.18%) | -3.90M (-4.18%) | -4.07M (+44.33%) | -2.82M (+4.06%) | -2.71M (+2.26%) | -2.65M (-2.57%) | -2.72M |
Ebit | -59.33M (-18.57%) | -72.86M (+21.15%) | -60.14M (+29.39%) | -46.48M (+4.12%) | -44.64M (-46.20%) | -82.97M (+64.23%) | -50.52M (+26.27%) | -40.01M (-69.76%) | -132.30M (+39.78%) | -94.65M (+1944.28%) | -4.63M (-19.76%) | -5.77M (+29.08%) | -4.47M (-42.62%) | -7.79M (-8.68%) | -8.53M (-4.48%) | -8.93M (-23.35%) | -11.65M (+48.60%) | -7.84M (+1.55%) | -7.72M (+34.49%) | -5.74M (+47.18%) | -3.90M (-4.18%) | -4.07M (+44.33%) | -2.82M (+4.06%) | -2.71M (+2.26%) | -2.65M (-2.57%) | -2.72M |
EBITDA | -58.73M (-23.50%) | -76.77M (+33.61%) | -57.46M (+32.40%) | -43.40M (-1.41%) | -44.02M (-50.47%) | -88.87M (+88.68%) | -47.10M (+30.40%) | -36.12M (-72.67%) | -132.14M (+39.40%) | -94.79M (+2084.10%) | -4.34M (-21.94%) | -5.56M (+26.94%) | -4.38M (-41.44%) | -7.48M (-12.31%) | -8.53M (-4.37%) | -8.92M (-22.70%) | -11.54M (+48.52%) | -7.77M (+0.65%) | -7.72M (+47.33%) | -5.24M (+40.86%) | -3.72M | 2.07M | -8.38M (+209.23%) | -2.71M (+8.84%) | -2.49M (-9.12%) | -2.74M |
Other Income / Expenses | ||||||||||||||||||||||||||
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 20K | - | - | - | - |
Other Non Operating Income | - | - | - | - | - | - | - | - | - | - | - | - | - | 10K | - | - | - | 490K | - | - | - | -5.58M | - | - | - | - |
Net Income | ||||||||||||||||||||||||||
Net Income From Continuing Operations | -53.84M (-22.98%) | -69.90M (+21.65%) | -57.46M (+32.40%) | -43.40M (+4.23%) | -41.64M (-48.11%) | -80.25M (+70.38%) | -47.10M (+30.40%) | -36.12M (-72.11%) | -129.49M (+39.79%) | -92.63M (+2034.33%) | -4.34M (-21.94%) | -5.56M (+30.21%) | -4.27M (-45.19%) | -7.79M (-8.68%) | -8.53M (-4.37%) | -8.92M (-23.43%) | -11.65M (+48.41%) | -7.85M (+1.68%) | -7.72M (+47.33%) | -5.24M (+34.36%) | -3.90M (-4.18%) | -4.07M (-51.43%) | -8.38M (+209.23%) | -2.71M (+1.12%) | -2.68M (-2.19%) | -2.74M |
Net Income | -53.84M (-22.98%) | -69.90M (+21.65%) | -57.46M (+32.40%) | -43.40M (+4.23%) | -41.64M (-48.11%) | -80.25M (+70.38%) | -47.10M (+30.40%) | -36.12M (-72.11%) | -129.49M (+39.79%) | -92.63M (+2034.33%) | -4.34M (-21.94%) | -5.56M (+30.21%) | -4.27M (-45.19%) | -7.79M (-8.68%) | -8.53M (-4.37%) | -8.92M (-23.43%) | -11.65M (+48.41%) | -7.85M (+1.68%) | -7.72M (+47.33%) | -5.24M (+34.36%) | -3.90M (-4.18%) | -4.07M (-51.43%) | -8.38M (+209.23%) | -2.71M (+1.12%) | -2.68M (-2.19%) | -2.74M |
Comprehensive Income Net Of Tax | -53.84M (-74.66%) | -212.45M (+269.93%) | -57.43M (+32.27%) | -43.42M (+4.12%) | -41.70M (-85.76%) | -292.93M (+522.86%) | -47.03M (+30.20%) | -36.12M (-72.11%) | -129.51M (+21.29%) | -106.78M (+2360.37%) | -4.34M (-21.94%) | -5.56M (+30.21%) | -4.27M (-88.62%) | -37.52M | - | - | - | - | - | - | - | - | - | - | - | - |